New EU HTA Guidance OKs Single-Arm Studies, But More Work Needed On Evidence Gaps

New guidance from the European Commission on clinical trial validity for forthcoming joint clinical assessments has eased some concerns about the generation of evidence for rare disease treatments and advanced therapies.